In mid-May, the FDA finally took a position on the controversial bisphosphonates prescribed as treatment for osteoporosis in postmenopausal women. (1) Of late the bisphosphonates class of drugs had been gathering an increasing amount of evidence of dire side effects Read on! →
Oral bisphosphonates have some more flak to fend off with findings of a new study coming in from Canada pointing that usage of the drug class puts the osteoporosis patients at an increased risk of developing serious inflammatory eye diseases Read on! →
At the May 2012 Annual Meeting of the Society-for-Investigative-Dermatology, one of the presentations, entitled “Denosumab is associated with dermatologic toxicity in the FDA-Adverse Events Reporting System (AERS) database,” discussed reports of “cutaneous ([skin] adverse events” (CAE) reported to the FDA’s Read on! →
Like the bisphosphonates, denosumab (trade names Prolia, Xgeva[i]) also prevents osteoclasts from removing old, damaged or worn out bone. It just does so via a different action than the bisphosphonates — an action that may turn out to have even Read on! →
Biphosphonate class drug Boniva also sold worldwide under the brand names Bonviva and Bondronat is now available for sale in the United States. The Food and Drug Administration has approved it’s use – prescription by doctors and distribution in pharmacies Read on! →
A study from Columbia University College of Dental Medicine warns that patients who were on long term bisphosphonates medication for treating osteoporosis were at risk of developing necrosis of bones in the jaw if they carried a variation of a Read on! →
You May Be Taking One of the Commonly Prescribed Drugs that Cause Osteoporosis: Here’s What You Can Do to Protect Yourself Did you know that drugs commonly prescribed to treat epilepsy, anxiety, insomnia, depression, schizophrenia and even restless leg syndrome Read on! →
Aromatase inhibitors are a class of drugs that are sometimes prescribed by doctors treating post-menopausal breast cancer. These inhibitors significantly reduce the production of estrogen in the body of the breast cancer patient. With the reduction of estrogen, there is Read on! →
My book, Your Bones, starts out with 30 pages’ worth of reasons why taking a bisphosphonate should be your last choice for healthy bones. Yes, there truly are that many reasons why relying on a bisphosphonate, like Fosamax, Boniva or Read on! →
Reclast is a Novartis drug from the bisphosphonate family (chemical name: zoledronic acid or zoledronate) that prevents the release of calcium from bones, thus reducing the rate of bone mass deterioration, especially in post-menopausal women. The chemical is also sold Read on! →